Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT CJS)
This study seeks to meaningfully address the U.S. opioid epidemic by comparing the effectiveness of two medications used to treat opioid use disorder, extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX), among adults currently incarcerated in U.S. jails and prisons at 5 distinct trial sites. This open-label, non-inferiority, head-to-head study design will allow providers, correctional and public health authorities, payers and policy makers' timely and relevant data to assess the effectiveness of XR-B (and XR-NTX) as potentially useful re-entry treatment option. Considering the majority of opioid users leaving jail or prison will inevitably return to their homes and communities untreated and prone to relapse, we believe findings from with important implications for limiting the greater public safety and societal costs of heroin, fentanyl, and prescription opioid addictions. Comparing retention-in-study-medication treatment, we hypothesize XR-B is non-inferior to XR-NTX.
Long Island Community Hospital | NYU Langone Health
The team at Long Island Community Hospital, an affiliate of NYU Langone Health, provides medical care to residents of eastern Long Island.
Long-term Cardiac Device Lead Management | NYU Langone Health
NYU Langone electrophysiologists are experienced in safely replacing cardiac device batteries or leads when necessary.
LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT
This study will evaluate the long-term safety and effectiveness of risdiplam (Evrysdi?),prescribed on the basis of the U.S. Package Insert (USPI) and clinician judgement, in adult and pediatric spinal muscular atrophy (SMA) patients.
Longitudinal Cohort of Older Individuals with Crohn s and Colitis: Differentiating the Fit from the Frail
Frailty is an age-related decline in multiple physiologic systems that confers significant vulnerability to health related changes.Frailty has been demonstrated to be a predictor of outcomes in numerous chronic disease states, including other inflammatory conditions such as rheumatoid arthritis and systemic lupus erythematosus. Frailty-related constructs have been used to risk stratify patients in fields such as oncology.Therefore, we hypothesize that frailty may impact effectiveness and safety of immunosuppressive therapies in older adults with IBD. Accurately defining a “fit” and “frail” older IBD patient will be an important first step to risk stratifying older individuals with IBD.The existing retrospective cohort studies of older adults with IBD have not been designed to assess aspects unique to older individuals with IBD. To date, concepts of frailty, physical and cognitive impairment have not been studied in IBD. Understanding these factors that may contribute to therapeutic effectiveness and safety in older adults is a step toward precision medicine. A well-characterized cohort of older adults with IBD will also have future uses. As older patients are frequently excluded from clinical trials, a prospective cohort can provide the framework to study existing and novel therapies in this vulnerable population. The LOGIC cohort will address priority research themes for older adults with chronic conditions identified by the American Geriatrics Society as well as challenges in IBD research identified by the Crohn’s and Colitis Foundation.
Lower Extremity Arterial Disease | NYU Langone Health
NYU Langone doctors can help you manage the symptoms of lower extremity arterial disease.
Lung Cancer | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, our specialists treat non-small cell and small cell lung cancer, and mesothelioma.
Lung Cancer Center | NYU Langone Health
Lung Cancer Center experts at NYU Langone’s Perlmutter Cancer Center provide individualized care for people with lung cancer and mesothelioma.
Lung Cancer Center Leadership | NYU Langone Health
NYU Langone’s Lung Cancer Center is led by a team of experts in lung cancer treatment and research.
Lung Cancer Screening Program | NYU Langone Health
NYU Langone’s Lung Cancer Screening Program offers testing for men and women at risk for lung cancer.